Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 14, 2017; 23(38): 7037-7046
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.7037
Table 3 Determinants for initiating hepatitis B virus vaccination sequence
Risk-factorUnivariate
Multivariable5
OR (95%CI)P valueOR (95%CI)P value
Female vs male0.61 (0.37-0.99)0.04
Age (per yr)1.00 (0.98-1.02)0.8
Parents from high endemic region1.52 (0.89-2.58)0.12
Traveled to high endemic region11.43 (0.83-2.45)0.19
Care in high endemic region1.45 (0.79-2.67)0.2
Transfusion0.28 (0.03-2.28)0.2
Tattoos1.26 (0.63-2.55)0.5
Piercing1.05 (0.66-1.67)0.8
Close contact with HBV+ individual1.14 (0.48-2.70)0.8
Men who have sex with men2.05 (0.97-4.34)0.062.53 (1.14-5.60)0.02
Nasal drug-use0.37 (0.13-1.07)0.070.41 (0.14-1.21)0.1
Intravenous drug-use3.42 (0.41-28.40)0.3
Long-term stay at a medical center1.02 (0.33-3.14)0.9
Previously incarcerated0.71 (0.24-2.06)0.5
HBV-prevalence of birth region
Low (< 2.0%)11
Intermediate (2.0%-8.0%)4.39 (2.35-8.19)< 0.0013.58 (1.85-6.95)< 0.001
High (> 8.0%)4.43 (2.24-8.75)< 0.0013.44 (1.65-7.15)0.001
Health insurance plan
Social security or CMU211
CMUc31.13 (0.35-3.62)0.80.76 (0.23-2.58)0.7
AME4, Other, or none4.54 (2.21-9.30)< 0.0012.60 (1.23-5.52)0.01
Number of life-time sexual partners
0-11
2-90.93 (0.47-1.87)0.8
≥ 100.75 (0.35-1.60)0.5